Clinical Trial Update: A Health Intervention to Prevent Depression Hepatitis C Patients [Phase 2, Phase 3]

View source ↗

Summary

The Phase 2/Phase 3 trial evaluating a health intervention to prevent depression in patients with Hepatitis C has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Major Depressive Disorder

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hepatitis C, Major Depressive Disorder | Phase 2, Phase 3 | Status: TERMINATED